Intimation of Schedule of Earning call to be held on May 27, 2025 for Audited Financial Results for the 4th Quarter and year ended March 31, 2025
Awaiting price reaction for this filing.
Aurobindo Pharma has informed the stock exchanges that it will hold an earnings call on May 27, 2025 at 8:30 AM IST to discuss its audited financial results for the fourth quarter and full year ended March 31, 2025. The call will be conducted via Zoom, and participants need to pre-register using the link provided. An earnings presentation will be uploaded to the company's website after the results are officially announced. The announcement was filed with both NSE (code: AUROPHARMA) and BSE (code: 524804) on May 19, 2025, as required under SEBI listing rules.
This is a routine regulatory disclosure informing investors about the date and time of the upcoming earnings call. It does not contain any new financial information, so it is unlikely to move the stock price on its own. Investors should watch the May 27 call for actual Q4 and FY25 results and management commentary.